Funder
Key Research and Development Program of China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Hegar B, Wibowo Y, Basrowi RW, Ranuh RG, Sudarmo SM, Munasir Z, Atthiyah AF, Widodo AD, Supriatmo, Kadim M, et al. The role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition. Pediatr Gastroenterol Hepatol Nutr. 2019;22:330–40.
2. Chen X. Human milk oligosaccharides (HMOS): structure, function, and enzyme-catalyzed synthesis. Adv Carbohydr Chem Biochem. 2015;72:113–90.
3. Deng J, Lv X, Li J, Du G, Chen J, Liu L. Recent advances and challenges in microbial production of human milk oligosaccharides. Syst Microbiol Biomanuf. 2020;1:1–14.
4. Zhang P, Zhu YY, Li ZY, Zhang WL, Mu WM. Recent advances on Lacto-N-neotetraose, a commercially added human milk oligosaccharide in Infant Formula. J Agric Food Chem. 2022;70:4534–47.
5. Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, et al. Safety of the extension of use of 2’-fucosyllactose (2’-FL) and lacto-neotetraose (LNnT) as novel foods in food supplements for infants pursuant to regulation (EU) 2015/2283. Efsa J. 2022;20(5):e07257.